Contact Us
Contact Information
For patients or physicians interested in learning more about our Phase 2a study evaluating the safety and efficacy of LIV-001 in patients with end stage liver disease, see: NCT04496479
Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania.